Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique — Stella

Home/HIV/Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

View on ClinicalTrials.gov

Recruiting

Back to HIV trials

Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

Trial locations(1 site)

Mozambique

Hospital Carmelo, Chokwé

Key details

Sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Enrollment target

~200 participants

Started

October 2024

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.